Journal
MEDICAL JOURNAL OF AUSTRALIA
Volume 213, Issue 3, Pages 134-139Publisher
WILEY
DOI: 10.5694/mja2.50698
Keywords
Clinical decision-making; Respiratory tract infections; Epidemics; COVID-19
Categories
Ask authors/readers for more resources
The rapid spread of severe acute respiratory syndrome coronavirus 2 led to the declaration of a global pandemic within 3 months of its emergence. The majority of patients presenting with coronavirus disease 2019 (COVID-19) experience a mild illness that can usually be managed in the community. Patients require careful monitoring and early referral to hospital if any signs of clinical deterioration occur. Increased age and the presence of comorbidities are associated with more severe disease and poorer outcomes. Treatment forCOVID-19 is currently predominantly supportive care, focused on appropriate management of respiratory dysfunction. Clinical evidence is emerging for some specific therapies (including antiviral and immune-modulating agents). Investigational therapies forCOVID-19 should be used in the context of approved randomised controlled trials. Australian clinicians need to be able to recognise, diagnose, manage and appropriately refer patients affected byCOVID-19, with thousands of cases likely to present over the coming years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available